Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Salvetti

Showing results (31-40 of 231) with videos related to

Pageof 24
Sort By:
The Laryngoscope|April 28, 2020
Cochlear Implantation in Neurological Patients: Case Report and Literature SurveyMaurizio Barbara, Valerio Margani, Rocco Costanzo, et al.
Neurology|July 16, 2014
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNSNitin K Sethi, Giovanni Ristori, Silvia Romano, et al.
F1000Research|August 23, 2018
Collaboration between a human group and artificial intelligence can improve prediction of multiple sclerosis course: a proof-of-principle studyAndrea Tacchella, Silvia Romano, Michela Ferraldeschi, et al.
Current Medicinal Chemistry|January 26, 2019
Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: The Case of EdaravoneCristina Agresti, Rosella Mechelli, Stefania Olla, et al.
Current Neuropharmacology|December 20, 2021
Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine TabletsLucia Moiola, Agostino Riva, Ferdinando Nicoletti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 17, 2008
Primary headache and multiple sclerosis: preliminary results of a prospective studyVeronica Villani, Luca Prosperini, Alessandro Ciuffoli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2022
Response to "Frailty in multiple sclerosis: A closer look at the deficit accumulation framework"Daniele Belvisi, Marco Canevelli, Girolama Alessandra Marfia, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in the real-world setting: Interim results from the Plegridy Observational ProgramMarco Salvetti, Sibyl Wray, Gereon Nelles, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2015
Progressive MS: from pathophysiology to drug discoveryMarco Salvetti, Douglas Landsman, Peter Schwarz-Lam, et al.
Current Neuropharmacology|March 31, 2021
Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical ViewpointMarika Alborghetti, Gianmarco Bellucci, Antonietta Gentile, et al.
Pageof 24

Showing results (31-40 of 231) with videos related to

Sort By:
Pageof 24
The Laryngoscope|April 28, 2020
Cochlear Implantation in Neurological Patients: Case Report and Literature SurveyMaurizio Barbara, Valerio Margani, Rocco Costanzo, et al.
Neurology|July 16, 2014
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNSNitin K Sethi, Giovanni Ristori, Silvia Romano, et al.
F1000Research|August 23, 2018
Collaboration between a human group and artificial intelligence can improve prediction of multiple sclerosis course: a proof-of-principle studyAndrea Tacchella, Silvia Romano, Michela Ferraldeschi, et al.
Current Medicinal Chemistry|January 26, 2019
Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: The Case of EdaravoneCristina Agresti, Rosella Mechelli, Stefania Olla, et al.
Current Neuropharmacology|December 20, 2021
Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine TabletsLucia Moiola, Agostino Riva, Ferdinando Nicoletti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 17, 2008
Primary headache and multiple sclerosis: preliminary results of a prospective studyVeronica Villani, Luca Prosperini, Alessandro Ciuffoli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2022
Response to "Frailty in multiple sclerosis: A closer look at the deficit accumulation framework"Daniele Belvisi, Marco Canevelli, Girolama Alessandra Marfia, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in the real-world setting: Interim results from the Plegridy Observational ProgramMarco Salvetti, Sibyl Wray, Gereon Nelles, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2015
Progressive MS: from pathophysiology to drug discoveryMarco Salvetti, Douglas Landsman, Peter Schwarz-Lam, et al.
Current Neuropharmacology|March 31, 2021
Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical ViewpointMarika Alborghetti, Gianmarco Bellucci, Antonietta Gentile, et al.
Pageof 24